Press Releases

Isodiol International Inc. Enters Hemp Beer and Related Functional Beverage Sector Through Its Subsidiary, IsoBev

August 20, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce the progress of its months-long efforts to develop new hemp-based beers and functional beverages. In May 2018, IsoBev Inc. (“IsoBev”), a wholly owned subsidiary of Isodiol, acquired …

Isodiol International Inc. Applauds the World Health Organization on Its Recommendation That Pure CBD Should Not Be Scheduled Within International Drug Control Conventions

August 17, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”),a global CBD leader and innovator, applauds the World Health Organization’s (WHO) historic recommendation, at the conference in Geneva, that pure CBD should not be scheduled within the International Drug Control Conventions. Some key findings from the WHO: …

Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry

August 16, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, in conjunction with Livecare is proud to announce the launch of ISOCare in North American and Latin American markets. ISOCare is an innovative secure platform for the cannabis treatment …

Isodiol International Inc. Announces Former IFBB Professional Bodybuilder, David Hawk, Joins Iso-Sport Management Team

August 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is proud to announce that it has entered into an agreement with David Hawk, fitness expert and a former IFBB professional bodybuilder, who ranked in the top 10 of …

ISODIOL INTERNATIONAL INC. APPOINTS BARINDER RASODE TO ITS ADVISORY BOARD

August 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is pleased to announce the appointment of Barinder Rasode to its advisory board. She will be focused on assisting the Company with its advocacy to various governmental and non-governmental …

ISODIOL INTERNATIONAL INC. LAUNCHES AUTOMATED RETAIL STRATEGY; PLANS NATIONAL NETWORK OF CBD KIOSKS

August 13, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is pleased to announce the launch of its automated retail strategy, with the Company planning to roll out a nation-wide network of branded kiosks, which will provide consumers with …

Isodiol International Inc. Announces Expansion of Kure Retail Stores in Arizona

August 9, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, announces its retail division, KURE ™, will begin its first phase of expansion on the west coast with the opening of seven locations in the Greater Phoenix market which …

Isodiol International Inc. Announces Partnership Between ISO-Sport and ALTIS, an Elite Training Environment for Athletes & Coaches

August 7, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce that Iso-Sport has entered into an agreement with ALTIS LLC (“Altis”), an Arizona based company that was built to bring Track & Field back to global prominence …

Marvin Washington Tackles Cannabis On The Green Rush Podcast

On this week’s episode of The Green Rush podcast, hosts Anne Donohoe and Lewis Goldberg spend time with Super Bowl champion and cannabis educator and activist Marvin Washington. After an impressive 11 year career on the NFL, Marvin has truned his attention to the cannabis industry as an entrepreneur, an educator, a spokesperson and activist. …

ISODIOL INTERNATIONAL INC. ANNOUNCES LETTER OF INTENT FOR ONGOING SUPPLY OF PHARMACEUTICAL GRADE CANNABIDIOL TO PURE GLOBAL CANNABIS INC. FROM BSPG LABORATORIES, LTD.

August 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader specializing in the development of pharmaceutical drug deliveries, health and wellness products and now supporting the pharmaceutical industry at large with BSPG Laboratories, LTD. recently approved CBD as an Active …

Isodiol International Inc. Introduces Isoderm Direct Effects Technology Nationally Via PBS Television

July 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in Finished Pharmaceutical Products …

Isodiol International Inc. Reports Fiscal Year 2018 Audited Financial Results

July 30, 2018 - Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in Finished Pharmaceutical Products …

Isodiol International Inc. Finalizes Share Consolidation

July 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical …

Isodiol International Inc. Outlines Strategy for Balanced, Long-Term Growth to Increase Shareholder Value

June 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, announces plans to pursue a focused business strategy designed to improve its market leadership and fully leverage the potential of recent acquisitions. “Over the past 6 months, we made significant …

Isodiol International Inc. Applauds the FDA’s Decision to Recognize the Medical Benefits of CBD at Higher Concentrations and Announces Corporate Restructure

June 27, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), applauds the FDA’s decision on the long-anticipated approval of GW Pharmaceutical’s (NASDAQ: …

ISODIOL INTERNATIONAL INC. ANNOUNCES BINDING AGREEMENT TO ACQUIRE 51% OF ROUND MOUNTAIN TECHNOLOGIES, LLC AND COMMENCES CERTIFIED ORGANIC HEMP FARMING IN NEVADA

June 12, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in …

Isodiol International, Inc. Announces May 2018 Revenues and Corporate Update

June 11, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in …

Isodiol International Inc. Announces KURE Corp Expansion Plans

June 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces that its …

ISODIOL INTERNATIONAL INC. COMPLETES ACQUISITION OF FARMTIVA INC. FOR 51% OWNERSHIP AND COMPLETES FIRST PLANTING OF FARM BILL COMPLIANT HEMP IN CALIFORNIA

June 4, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces that it …

Isodiol International Inc. Announces Closing of Strategic Non-Brokered Offering for Total Proceeds of $18 Million

May 28, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces the closing …

ISODIOL INTERNATIONAL INC. ANNOUNCES LETTER OF INTENT TO SUPPLY 99.5%+ CANNABIDIOL ISOLATE TO SUNDIAL

May 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, is pleased to …

Isodiol International, Inc Increases Non-Brokered Offering – Retains Clarus Securities As Advisor

ISODIOL INCREASES SIZE OF PRIVATE PLACEMENT TO $18 MILLION WITH THE UPSIZE LED BY ANSON FUNDS May 4, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical, health, and wellness products and now supporting the pharmaceutical industry …

Isodiol Announces To Supply 99.5%+ Pharma-Grade Cannabidiol To Zenabis

With the MHRA approval for the manufacturing of the CBD Isolate, Isodiol is able to export its pure, natural CBD from the United Kingdom into global markets. May 4, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical …

Isodiol International, Inc – Acquire 51% of Farmtiva & Commence Hemp Farming In California

The exclusive partnership with the Imperial Valley Conservation Research Center and Farmtiva will harvest the first legally grown hemp in California in 24 years under the Agricultural Act of 2014 § 7606 (“2014 Farm Bill”). May 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a …

Isodiol International Inc. Completes Acquisition of KURE™ Corp

Kure has Established High End Stores Throughout the United StatesKure annualized unaudited fiscal 2018 revenues of $10.7m CDN   May 1, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that …

Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient

Isodiol’s subsidiary, BSPG Laboratories, LTD. has commercialized manufacturing of pure, natural CBD as an API for the pharmaceutical and research industry. April 26, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical actives and health and wellness …

Isodiol International Inc. Announces the Launch of 3 New Cannabidiol (CBD) Product Categories with Level Brands Inc.

April 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, and Level Brands Inc. (NYSE American: LEVB), an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading …

Isodiol International, Inc Announces Major International Expansion & Innovation Due To Global Demand

Isodiol has signed the definitive agreement on industry leading CBD patents and strategic assets and announces international expansion with Scythian Biosciences Corp and Liberty Health Sciences Inc along with strategic investment led by the Serruya Private Equity Group. April 17, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” …

Update : Isodiol International, Inc

April 13, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products is clarifying that the current halt on the stock is management requested pending material news.  Management anticipates resumption of trading on or …

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Agrima Botanicals

April 6, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Agrima Botanicals Corp. (“Agrima”), a Canadian Licensed Producer, …

Isodiol International Inc Announces Retail Distribution of Pot-O-Coffee

April 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the product placement of Pot-O-Coffee and Pot-O-Tea in select Winn-Dixie stores throughout the East Coast. With the past acquisition of …

Isodiol International Inc. Provides Update for Shareholders; Announces Extension of Deadline for Biosynthesis Pharma Group Acquisition

April 3, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, announces that it is has extended the period to complete the acquisition of Biosynthesis Pharma Group (BSPG) to April 30, 2018. The …

Isodiol International Inc. Signs Definitive Agreement To Acquire Azure Bottling, LLC.

March 26, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is proud to announce that its wholly owned subsidiary, IsoBev Inc., has reached a definitive agreement to acquire 100% of Azure Bottling …

Isodiol International Inc. Signs Letter of Intent To Acquire Leading Specialty Vape Retailer Kure Corp

March 23, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has signed a letter of intent (LOI) to acquire 100% of KURE™ Corp,  a leading …

Isodiol International Inc. Signs Partnership Agreement With Kawacatoose First Nation

March 19, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”),a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, announces it has signed a partnership agreement with Kawacatoose First Nation (KFN), a leader and forward-thinking Band with operations and land in Saskatchewan, …

Isodiol International Inc. Announces Conference Sponsorship At Arnold Sports Festival Through Iso-Sport

March 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, proudly announces that ISO-Sport will be sponsoring the 2018 Arnold Sports Festival from March 1-4, 2018 in Columbus, Ohio. The World Anti-Doping …

Isodiol International Inc. Reports Profitable Q3 Financial Statements

March 1, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, reports unaudited Q3 revenues for the period ended December 31, 2017 of $5.89 million CDN a for net operational profit of $202,254 …

Isodiol International Inc. Provides Update On Be Tru Wellness, Announces New Distribution Agreement With Threshold Enterprises

February 22, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that its wholly owned subsidiary Be Trū Wellness (Be Tru) has signed a distribution agreement with Threshold Enterprises. …

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group INC.

February 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc. (CN Pharma), …

Isodiol International Inc. Announces Partnership With Europe’s Leading MMA Promotion, Cage Warriors

February 12, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of wellness products, proudly announces that it has reached a partnership agreement with Cage Warriors, Europe’s leading Mixed Martial Arts (MMA) promotion through its brand ISO-Sport.  The Company …

Isodiol International Inc. Is Proud To Announce The Appointment of Winter Athlete Brand Ambassadors

February 8, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announces that Jazmine Fenlator, Kiley McKinnon, Kimani Griffin, Faye Gulini, and Julia Marino have been appointed as brand ambassadors for ISO-Sport to …

Isodiol International Inc. Receives Regulatory ( ANVISA ) Approval For Isodiolex For The Treatment of Epilepsy and Parkinson’s Disease

February 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has received approval from the Brazilian Health Regulatory Agency (ANVISA) This product will be placed on the Special …

Isodiol International Inc. Brand Ambassador and Spokesman Marvin Washington Making Headway On CTE Discussion At Superbowl LII

January 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announces that Marvin Washington, brand ambassador and spokesman for ISO-Sport, has been speaking on multiple platforms to discuss and raise awareness surrounding …

Isodiol International Inc. Brand Ambassador and Spokesman, Marvin Washington, To Discuss CTE At Superbowl LII

January 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that Marvin Washington, brand ambassador and spokesman for Isodiol, will be speaking on the cause of the neurological disorder Chronic …

Isodiol International Inc. Announces Licensing Agreement With Livecare Health Canada Inc. and Appoints Dr. Amit Mathur To Medical Advisory Board

January 26, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a licensing agreement with Livecare Health Canada Inc. (Livecare), an organization founded and operated …

Isodiol International Inc. Announces Extension of Licensing Agreement With Kathy Ireland and Level Brands

Terms of License Agreement extended to 10 years, Territory expanded to worldwide January 22, 2018 – Vancouver, BC – Isodiol International Inc., (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has signed an amendment to the license agreement …

Isodiol International Inc. Signs Letter of Intent to Acquire 100% of Green Island Naturals

January 12, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that is has signed a Letter of Intent to acquire 100% of the CBD assets of Green Island Naturals. Green …

Isodiol International Inc. Signs Binding Supply Agreement with Namaste Technologies Inc.

January 12, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bio-active phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a binding agreement with Namaste Technologies Inc. (“Namaste”)(CNSX: N)(OTCBQ: NXTTF)(FRA: M5BQ), an online retailer …

Isodiol International Inc. Announces Letter of Intent To Import 99%+ Pure Pharma-Grade Cannabidiol To Canada From U.K. With Nuuvera

January 11, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a letter of intent (LOI) with Nuuvera Holdings Limited (TSXV:NUU), a global cannabis company …

Isodiol International Inc. Provides Update on Be Tru Organics, Announces New Distribution Agreement

January 9, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce Be Trū Organics™ has signed a distribution agreement with United Natural Foods Inc (UNFI), the largest publicly traded …

Isodiol International Inc. Signs Licensing Agreement With Level Brands Inc. and It’s Chairlan Emeritus and Chief Brand Strategist Kathy Ireland

Isodiol to begin marketing new line of phytoceutical products for kathy ireland® Health & Wellness and Ireland Men One January 8, 2018 – Vancouver, BC – Isodiol International Inc., (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has …

Isodiol International Inc. Announces Non-Binding Agreement With Licensed California Marijuana Manufacturer For Pot-O-Coffee

January 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that is has signed a non-binding agreement with a California based licensed marijuana manufacturer for its Pot-O-Coffee brands. …

Isodiol International Inc. Closes Second Tranche of Strategic Financing for Total Proceeds of $30,100,000 CDN

December 27, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that, further to its news release dated December 19, 2017, the Company has closed the second tranche of its …

Isodiol International Inc Closes First Tranche of Strategic Financing

December 21, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that, further to its news release dated December 19, 2017, the Company has closed the first tranche of …

Isodiol International Inc Announces Strategic $30,000,000 CAD Financing

December 19, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce it is in the process of closing a non-brokered private placement (the “Offering”) of up to $30,000,000 CAD …

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

December 17, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has entered into a binding agreement to acquire the Biosynthesis Pharma Group (BSPG), an industry …

Isodiol International Acquires Global Rights to Produce Products Under an Innovative Delivery System Patent

December 15, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that its division, C3 Global Biosciences (C3GBS) has agreed in principle to acquire the rights to become the exclusive worldwide …

Isodiol International Inc. Initiates Implementation of Blockchain Technology for Payment Processing

December 14, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the Company has initiated Phase 1 of implementing cryptocurrency through BitPay, a global blockchain payments technology platform. Founded …

Isodiol International Inc. Provides Update on Be Trū Organics™, Announces New Distribution Channel

December 13, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce Be Trū Organics™ has commenced the process of distributing product to Erewhon Natural Foods, a premier supermarket chain …

Isodiol International Inc. Executes Definitive Agreement to Acquire 100% of C3 Global Biosciences™

December 8, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has entered into a definitive agreement with C3 Global Biosciences™ (C3GBS), a cause-driven organization committed to developing sustainable …

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™

December 8, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has finalized the definitive agreement to acquire 100% of Be Trū Organics™, a cause driven organization …

ISODIOL INTERNATIONAL INC. TO PRESENT, EXHIBIT AT 25TH ANNUAL AMERICAN ACADEMY OF ANTI-AGING MEDICINE WORLD CONGRESS

Dr. Ronald Aung-Din to discuss power of patented Direct Effects Technology™ combined with CBD and its effect on neuropsychiatric disorders DECEMBER 7, 2017 – LAS VEGAS – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that …

Isodiol International Inc. Announces Binding Agreement to Acquire 25% of Canadian National Pharma Group Inc.

December 6, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Binding Agreement to acquire 25% of Canadian National Pharma Group Inc., a …

Isodiol International Inc. Signs Binding Agreement to Acquire 100% Stake in Be Trū Organics™

December 1, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a binding agreement to acquire 100% stake in Be Trū Organics™, a cause …

Isodiol International Inc. Announces Appointment of Dr. Ronald Aung-Din as an Advisor, Closes Strategic Financing

November 29, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the appointment of Dr. Ronald Aung-Din as a Medical, Science and Development Advisor to the Company. Dr. Aung-Din, …

Isodiol International Inc Signs Binding Agreement to Acquire 100% of C3 Global Biosciences

November 24, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a binding agreement to acquire 100% of C3 Global Biosciences (C3GBS), a cause-driven …

Isodiol International Inc. Signs Definitive Agreement to Acquire Bradley’s Bioscience Inc., and Closes Strategic Financing

November 22, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a definitive agreement in connection with its previously announced (https://isodiol.com/isodiol-international-signs-letter-intent-acquire-bradleys-bioscience/) Letter of Intent …

Isodiol News: Isodiol International Inc. Upgrades to OTCQB

November 21, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that Isodiol’s common shares have been approved for trading on the OTCQB Venture Market in the United States. The trading …

Isodiol International Acquires Global Rights to produce products under an Innovative Delivery System Patent

November 17, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) A global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it has acquired international licensing rights for IsoDerm™ as well as five other proprietary pharmaceutical compounds to be delivered …

ISODIOL INTERNATIONAL SIGNS LETTER OF INTENT TO ACQUIRE BRADLEY’S BIOSCIENCE

ISODIOL INTERNATIONAL INC. SIGNS LETTER OF INTENT TO ACQUIRE BRADLEY’S BIOSCIENCE INC., EXPANDS INTO VAPING AND THC ADDITIVE INDUSTRIES  November 9, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to …

Isodiol International Inc. Announces Update on Commercialization Strategy for Pot-O-Coffee Brand, Acquisition of Culinary Coffee

November 1, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has committed distribution licenses for its Pot-O-Coffee brands in the states of Oregon, Washington, Illinois and …

Isodiol International Inc. Announces Launch of Market’s First Hops-Derived CBD Products

October 23, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce the launch of the market’s first non-cannabis, highly bioactive cannabinoid, CBD, derived from the hops plant; a globally …

Isodiol International Inc. Provides Investor Update

October 18, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, reports the Canadian Securities Exchange (CSE) will continue to welcome companies with links to the US cannabis market, a contrast to the statement …

Isodiol International Inc to Implement Blockchain Technology for Payment Processing

October 17, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it is in the final stages of advanced due diligence for implementing Blockchain technology for payment processing.  The company …

Isodiol International Provides Corporate Update

October 13, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announces fiscal 2018 Q2 revenues of it’s wholly owned subsidiary ISO International LLC of, $4.07 million USD ($5.1 million CDN) compared to fiscal 2018 …

Isodiol International to Present at New West Summit Cannabis Conference in Oakland

October 10, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today Marvin Washington, former NFL athlete and brand ambassador for Isodiol, will be speaking at the New West Summit Cannabis Conference being held at …

Isodiol International Inc. Commences Approval Process to Bring Isodiol to Chilean Market

October 4, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce that the Company has officially initiated the approval process to begin exporting its flagship product, Isoderm to Chile. Marcos Agramont, …

Isodiol International Inc. Announces Formation of IsoLabs, Plans to Expand With THC Product Offerings

September 28, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce the formation of IsoLabs International, a new division that will focus in the licensed medical marijuana markets in both North America …

Isodiol International Inc. Announces North 6th Agency as PR and Social Media Agency of Record

September 27, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to name North 6th Agency (N6A), an award-winning brand communications agency based in New York and Toronto, the Company’s PR …

Isodiol International Inc. Commences Process to List on the Australian Stock Exchange

September 12, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it has initiated the process of obtaining a secondary listing on the Australian Stock Exchange (ASX) and expects this process to be …

Isodiol International Inc. Announces Launching Phytoceutical Division

September 5, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to be launching a new Phytoceutical Division that will focus on cannabinoids and terpenes derived from non-cannabis sources. Proprietary …

Isodiol International Inc Announces Distribution Agreement for South America

August 30th, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces it has signed a distribution partnership with FarmaUSA™, a leading global wholesale distributor of imported pharmaceutical products in South America. This is the latest …

Isodiol International Inc. Reports Q1 Unaudited Financial Statements

August 29th, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products reports Q1 revenue for the period ended June 30, 2017 of $2,740,542 compared to Q1 revenue in 2016 of $47,185.  The substantial increase in …

Isodiol International Inc. Provides Sponsorship At The US Autism Asperger Association Conference

August 28, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces it proudly exhibited at the US Autism & Asperger Association (USAAA) (usautism.org/conferences) conference this past weekend in Portland, Oregon and sponsored Dr. …

Isodiol International Inc. Announces $25,000,000 Convertible Debenture Financing

August 21, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products announces it has signed a convertible debenture financing for $25,000,000 CDN with Alumina Partners. Marcos Agramont, CEO of Isodiol stated, “Our focus remains …

Isodiol International Inc. Announces Conference Sponsorship in Brazil

August 9, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products announces it is proudly sponsoring the 50th Anniversary of IV International and XXIV Brazilian Congress of ABENEPI (Brazilian Association of Neurology and Child Psychiatry and Related …

Isodiol International Inc. Corporate Update

August 4, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products announces unaudited July 2017 revenue numbers of its wholly owned subsidiary ISO International LLC of $1,358,787 USD. Marcos Agramont CEO of Isodiol stated, …

Isodiol International Inc. Announces OTC Symbol Change

August 2, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (“Isodiol or the “Company“)  is pleased to announce that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s OTC voluntary symbol change from “LAGBF” to “ISOLF” to better reflect the Company’s current name. The changes will be …

Isodiol International Inc. announces unaudited quarterly profit of Iso International LLC.

July 26, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017. Iso International LLC …

Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution

July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com). Canopy Growth is the world’s …

Isodiol International Inc. Announces Corporate Update

July 11, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the …

Isodiol International Inc. receives regulatory (ANVISA) approval for Isoderm for the treatment of Epilepsy and Parkinson’s

July 6, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has received approval from the Brazilian Health Regulatory Agency (ANVISA) for the approval of its pharmaceutical grade …

Isodiol Internation Inc. announces appointment Daniel Zuckerman as VP of US sales

June 26, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has recruited Mr. Daniel Zuckerman to serve as the company’s Vice-President, US Sales. Mr. Zuckerman has worked …

Isodiol International Inc. establishes operations in Mexico and will commence shipment of cannabinol products

June 21, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has established operations in Mexico and will commence shipment of its Cannabinol products throughout Mexico within the …

Isodiol International inc. commences approval process for its pharmaceutical products through the Brazilian Health Regulatory Agency (ANVISA)

June 19, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has initiated the drug approval process through the Brazilian Health Regulatory Agency (ANVISA) for the approval of …

Isodiol International Inc. over subscribes private placement and closes second tranche for total proceeds of $4,142,070 CDN

June 16, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce the closing of the second tranche of its non-brokered private placement (the “Private Placement”). The second tranche consisted …

Isodiol International takes major sponsorship role at the NY Cannabis World Congress Business Expo

June 14, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce we are one of the key sponsors at the NY Cannabis World Congress & Business Expo this June …

Isodiol International announces closing of 100% of a cannabis-infused beverage company, Pot-O-Coffee

June 12, 2017 – Vancouver, Canada – Isodiol International In.c (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol Interational”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today announced that it has completed the transaction of a definitive agreement to acquire the assets of a cannabis-based beverage company …

Laguna Blends Inc. announces name change and ticker symbol change

June 7, 2017 – Vancouver, Canada – Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce that, following its previously announced acquisition of ISO International, LLC on May 15, 2017, the Company will be changing its name to “Isodiol International Inc.” (the “Name Change”) and Canadian Securities …

Laguna Blends announces corporate update and appointment of director

June 5, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of May 2017. The Company recorded sales of $1,615,694 CAD for the …

Laguna Blends Announces LOI to Acquire 100% of a Cannabis-Infused Beverage Company, Pot-O-Coffee

May 30, 2017 – Vancouver, Canada – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce it has entered into a Binding Letter of Intent (“LOI”) to acquire 100% of an innovative cannabis company with product lines under the brand Pot-O-Coffee. Isodiol COO Troy Nihart stated, “We …

Laguna Blends Announces Isodiol as Title Sponsor at the Autism One Conference

May 26, 2017 – Vancouver, Canada – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce it is the title sponsor at this week’s Autism One Conference in Colorado. This is the 15th Annual conference which will see a total of approximately 1500 conference attendees and 60 …

Laguna Blends Announces Closing of First Tranche of Private Placement

May 23, 2017 – Vancouver, Canada – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce the closing of the first tranche of its private placement announced on May 17, 2017 for proceeds of $2,245,116. The Company has issued 18,709,300 Units at $0.12 per Unit. Each Unit …

Laguna Blends Completes Acquisition of Isodiol and Announces Private Placement for up to $4,000,000 and Change of Director and Officer

Vancouver, British Columbia – May 18, 2017 – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce that pursuant to the terms of a share exchange agreement dated April 27, 2017 (the “Agreement”) with ISO International, LLC, a limited liability company organized under the laws of the …

Laguna Blends to Acquire 100% Stake in a Global Cannabis Leader with Unaudited Annualized Sales of Approximately $12,000,000 USD

March 13, 2017 – Vancouver, Canada – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce that it has signed a letter of Intent (LOI) to acquire 100% interest of a global Cannabis leader with unaudited annualized sales of $12,000,000 USD and adjusted EBITDA of $1,588,000 USD. …

Laguna Blends Announces Addition of Soheil Samimi to the Board of Directors

March 10, 2017 – Escondido, CA – Laguna Blends Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Laguna”) is pleased to announce that it has appointed Soheil Samimi to its Board of Directors effective immediately. Mr. Samimi background includes management positions within leading technology companies, as well as being the successful founder of …

CBD Innovator and Supplier Isodiol Hosts “Cannabis vs. Opiates” Panel at the California Cannabis Business Expo

March 8, 2017 – Carlsbad, CA – As Southern California’s most innovative hemp cannabinoid product manufacturer, Isodiol is proud to be associated with pro athletes and doctors at the California Cannabis Business Expo in San Diego March 5-8. In addition to presenting innovative pharmaceutical grade and full-spectrum CBD finished products, Isodiol is sponsoring a panel …

Isodiol Launches IsoSport™ Product Line with Rebound Magazine at NBA All Star Weekend

San Diego, CA, February 16, 2017 – Partnering with Rebound Magazine, Isodiol unveils its new IsoSport™ line of hemp-infused high performance products for athletes at the NBA All Star Weekend in New Orleans, LA. This year’s star-studded weekend runs Friday, February 17 through Sunday the 19th. IsoSport™ is proud to be part of this event …

Isodiol’s Hemp CBD-Infused Alkaline Water Offers Next Big Splash in the Functional Drink Market

It’s a new year and Isodiol is ready to make a splash in the functional drink market with its new wave of hemp CBD-infused alkaline waters. Everyone knows the importance of drinking water to stay hydrated, healthy and even to lose weight, but not all water is created equal.

Next Level Hydration and Cannabinoid Wellness Support in a Bottle

Proper hydration is essential to life—day in and day out. Cannabinoids are essential to your endocannabinoid system, offering support for wellness. Now you can get the best of both in our hemp cannabinoid water options. Created by a team of doctors, the unique formulations in CBD Naturals™ and Hemp Rain™ deliver hydration and cellular nutrients …

New Year’s Resolution Time…and Cannabinoid Wellness Awaits!

It’s that time of year again—time to look back, reassess, appreciate where you’ve been, give yourself credit for what you’ve accomplished, and be honest about what you can do better in 2017. Equally important, it’s time to get real and make your goals tangible by making them actual plans. How do you do that? You …

IsoDerm CBD: Novel Non-Systemic Cannabinoid Therapy

MAJOR ANNOUNCEMENT ON CANNABINOID THERAPY For individuals and families seeking cannabinoids (parts of the cannabis plant) for neurologic, psychiatric and pain conditions take note and spread the word.   Indications in these three main categories include: Spasticity muscle spasms tremor headache neuropathies and neuropathic pain seizures anxiety attentional and focus problems cognitive blunting social isolation …

Nano Ultra™ Takes Cannabinoid Support to a Whole New Level

Nano Ultra™ is a water-based concentrate that is powered by this science. It can be added to water-soluble products, like water and beverages, in general. It’s convenient to use and delivers optimal results. Not sure how to get the best value and results from cannabinoid products? Find out how science can help you decide. When …

Nano-Amplified Cannabinoids Innovates Bottled Water – and Consumer Products

Water: It makes up nearly 75% of the human body and is essential for life. Bottled water is everywhere you look these days. According to market research firm Mintel, the bottled water industry sales topped $15 billion in 2015. They expect those sales to increase by nearly 35 percent by 2020. A Clear Choice in …

Cebediol™ Simplifies and Maximizes CBD Wellness Benefits

In these busy modern lives we lead, everyone can benefit from getting the most from their efforts and having one less thing to think about. That applies to efforts we take for wellness, too. For that reason, we at Isodiol created Cebidiol™. With one single daily use, this unique formulation allows you to enjoy the …

HenePlex™ Delivers Great Value in a Synergistic Blend

Nano-amplified HenePlex™ offers superior delivery. This water-based proprietary blend of over 75 botanical terpenes and non-psychotropic cannabinoids is optimally bioavailable. Cutting edge scientific technology makes hemp-based products a user-friendly, great value. As the saying goes, facts are facts. And science trumps opinion every time. Isodiol remains at the cutting-edge of scientific technology when it comes …

Cannabinoids: Revolutionizing Sports PERFORMANCE

Athletes of all ages – from youth to the pros – push their bodies to the limit. Wear and tear are simply “par for the course”. It is likely that you’ve seen television commercials touting the swapping six to eight pain pills from Brand X for just two of Brand Y. Putting pain management under …

Myth Busting Hemp History – the Humble Wonder Plant

Hemp is more than just a controversial plant. It is actually an integral part of our global history, dating back over 10,000 years. In fact, until 1883, hemp was the world’s largest agricultural crop. It has over 10,000 uses, and none of them have to do with THC; hemp has no psychotropic effect, as THC …

Can You Get High from Hemp or CBD Oil?

Over the last few decades, marijuana has steadily gained popularity. And there is no going back. Still, despite all the media buzz about the health benefits of cannabis, it is still largely associated with psychotropic effects. Due to years of suppression of this plant, most people still assume getting medical assistance from cannabis – via …

Cannabinoids May Change Your Mind About Cannabis

Cannabinoids are a natural substance that have attracted a lot of attention recently. Cannabidiol or “CBD” is a naturally occurring botanical concentrate in the oil that’s high in the compound and is one of the 85 cannabinoids identified in the cannabis hemp plant. Don’t want the “high”? Then you’ll probably like the other side of …

Earthy Hemp Oil – A Relic by Today’s Standards

Cannabinoids are botanical compounds that naturally occur in the cannabis plant; hemp oil and marijuana are from the cannabis species. Hemp and Cannabinoids For the same reasons why people seek decaffeinated coffee, non-psychoactive cannabinoids cannot get you “high” and could be viewed as a “decaf” cannabinoid. Hemp is a robust source of non-psychoactive cannabinoids but, …

What is CBD Isolate?

With the rapid growth of the CBD industry and constant advances in its technology, there are a lot of terms floating around that are unfamiliar, if not confusing, to many people. “Nano-Amplified CBD” is one of them. While the science and biological make-up of CBD is the subject of much research and scholarly articles, it …

Endocannabinoid System (ECS) – Essential to Your Health and Wellbeing

Your body is smart, maybe smarter than you think. In fact, it has a system you may not have heard of and/or may not understand. Your endocannabinoid system or ECS is responsible for some of the most important functions in your body. You could even say it is essential to life itself. What is the …

Isodiol Joins Multi-Billion Dollar Bottled Water and Water Enhancer Industries with Hemp CBD Offerings – And Joins National Hemp Association

At Isodiol, we’re committed to continually developing superior CBD products for the health and vitality of individual consumers and companies domestically and abroad. Toward this end, we are proud to announce our latest advancements in the U.S. market

What is Hemp and What Does It Do?

What is Hemp? What is hemp, you might be wondering. Well, hemp is a member of the Cannabis Sativa group of plant species. It is or was used mainly for industrial purposes due to it’s rapid growth. Although related to Cannabis Sativa hemp has lower concentrations of THC and higher concentrations of cannabidiol (CBD). It actually helped …